Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Study Closure and Reporting

Posted on By

Standard Operating Procedure for Closing and Reporting Clinical Research Studies

Purpose

This SOP outlines the procedures for closing a clinical trial or clinical study and reporting the results. The goal is to ensure a systematic, organized, and compliant study closure process and accurate reporting of study findings.

Scope

This SOP applies to all personnel involved in study closure and reporting, including principal investigators, clinical research coordinators, data managers, and other study team members.

Responsibilities

  • Principal Investigator (PI): Oversees study closure and reporting, ensuring compliance with regulatory requirements and study protocols.
  • Clinical Research Coordinators: Assist in closing out the study site and completing all necessary documentation.
  • Data Managers: Ensure all data is cleaned, locked, and archived as required.
See also  SOP for Project Management and Coordination

Procedure

  • Preparation for Study Closure:
    • Ensure all study activities are complete and participants have completed the final visit.
    • Reconcile all study data, ensuring its accuracy and completeness.
    • Perform final monitoring visits and address any outstanding issues.
  • Documentation and Archiving:
    • Complete and submit all required study documents, including case report forms (CRFs), source documentation, and regulatory submissions.
    • Archive study records in a secure and organized manner according to regulatory requirements and institutional policies.
    • Document study closure in the study master file and maintain the file for future reference.
  • Data Cleaning and Locking:
    • Review study data for accuracy and consistency.
    • Resolve data queries and discrepancies
before data lock.
  • Lock the study database once all data is clean and ready for analysis.
  • Reporting:
    • Prepare the final study report, including results and safety findings.
    • Submit the final study report to regulatory authorities, the sponsor, and other relevant parties as required.
    • Publish or present study findings in scientific journals or conferences, as appropriate.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator
    • CRF: Case Report Form

    Documents

    • Study records and source documentation
    • Case report forms (CRFs)
    • Study master file
    • Data cleaning and lock documentation
    • Final study report

    References

    • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)
    • Institutional policies and procedures

    SOP Version

    Version: 1.0

    See also  SOP for Randomization and Allocation Procedures
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: Clinical Studies: SOP for Documentation and Record-Keeping
    Next Post: SOP for Financial Management and Budgeting

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version